Mark Puder MD PhD
Professor of Surgery, Boston Children's Hospital
Join to View Full Profile
300 Longwood Ave/Fegan 3Children's HospitalBoston, MA 02115
Phone+1 617-355-3038
Dr. Puder is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Boston Children’s HospitalFellowship, Pediatric Surgery, 1999 - 2001
Beth Israel Deaconess Medical CenterResidency, Surgery, 1988 - 1998
Harvard UniversityPhD, 1993 - 1997
Yale-New Haven Medical CenterResidency, Pediatrics, 1986 - 1988
Vanderbilt University School of MedicineClass of 1986
Certifications & Licensure
MA State Medical License 1991 - 2025
American Board of Surgery Surgery- American Board of Surgery Pediatric Surgery
Awards, Honors, & Recognition
- Boston Magazine Castle Connolly, 2013
- Fellow (FACS) American College of Surgeons
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Cholestasis Prevention: Efficacy of IV Fish Oil Start of enrollment: 2007 Jul 01
- Cholestasis Reversal: Efficacy of IV Fish Oil
- A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB Start of enrollment: 2018 Nov 21
- Join now to see all
Publications & Presentations
PubMed
- Fish oil lipid emulsion compared with soybean oil lipid emulsion in pediatric patients with parenteral nutrition-associated cholestasis: A cost-effectiveness study.Massimiliano Povero, Kathleen M Gura, Muralidhar H Premkumar, Lorenzo Pradelli, Mark Puder
JPEN. Journal of Parenteral and Enteral Nutrition. 2025-02-01 - 1 citationsAchieving Enteral Autonomy in Children with Intestinal Failure Following Inpatient Admission: A Case Series.Allison Fialkowski, Kathryn Broyles, Brittany DePaula, Alejandro Flores, Megan Gray
The Journal of Pediatrics. 2024-12-01 - 1 citationsIntestinal failure-associated liver disease model: a reduced phytosterol intravenous lipid emulsion prevents liver injury.Scott C Fligor, Thomas I Hirsch, Savas T Tsikis, Amy Pan, Mikayla Quigley
Pediatric Research. 2024-11-27
Press Mentions
- Alcresta Therapeutics Announces Preclinical Data Showing ALC-078 Cartridge Use in SBS Model Associated with Reduced Dependence on Parenteral NutritionMarch 16th, 2023
Worth the Fight: Finding Care for Short Bowel SyndromeApril 23rd, 2019
An Evolving Story of Translational Research: A Decade After the Jacobson Promising Investigator AwardDecember 30th, 2017- Join now to see all
Grant Support
- A 90 day, Phase 3, Open Labeled Exploratory Study of RELiZORB to Evaluate Safety, Tolerability, and Nutrient Absorption in Children with Short Bowel Syndrome who are Dependent on Parenteral NutritionBOSTON CHILDREN'S HOSPITAL2021–2028
- Cholestasis Reversal (Phase Ll): Efficacy Of LV Fish OilFood And Drug Administration2008–2010
- Cholestasis Prevention: Efficacy Of IV Fish OilFood And Drug Administration2008–2009
- Mechanisms Of Hepatic Steatosis PreventionNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2009
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
